EGFR plasma mutation in prediction models for resistance with EGFR TKI and survival of non-small cell lung cancer

BACKGROUND: This study aims to clarify the prognostic role of epidermal growth factor receptor (EGFR) mutations in plasma of non-small cell lung cancer (NSCLC) for resistance to tyrosine kinase inhibitor (TKI), in correlation with clinical characteristics. A total of 94 Adenocarcinoma, clinical stag...

Descripción completa

Detalles Bibliográficos
Autores principales: Phan, Thang Thanh, Tran, Bich-Thu, Nguyen, Son Truong, Ho, Toan Trong, Nguyen, Hang Thuy, Le, Vu Thuong, Le, Anh Tuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339636/
https://www.ncbi.nlm.nih.gov/pubmed/30661185
http://dx.doi.org/10.1186/s40169-019-0219-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339636/
https://www.ncbi.nlm.nih.gov/pubmed/30661185
http://dx.doi.org/10.1186/s40169-019-0219-8

Ejemplares similares